Stamatia Vassiliou

RXP 407, a phosphinic peptide, is a potent inhibitor of angiotensin I converting enzyme able to differentiate between its two active sites

Vincent Dive, Jöel Cotton, Athanasios Yiotakis et al. · Proceedings of the National Academy of Sciences · 1999 · 177 citations

Life Sciences, Biochemistry, Pharmacology +15

Phosphinic Pseudo-Tripeptides as Potent Inhibitors of Matrix Metalloproteinases:  A Structure−Activity Study

Stamatia Vassiliou, Artur Mucha, Philippe Cuniasse et al. · Journal of Medicinal Chemistry · 1999 · 111 citations · Full text

Pharmacy, Biochemistry, Medicinal Chemistry +12

Design, Synthesis, and Evaluation of Novel Organophosphorus Inhibitors of Bacterial Ureases

Stamatia Vassiliou, Agnieszka Grabowiecka, Paulina Kosikowska et al. · Journal of Medicinal Chemistry · 2008 · 93 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

RXP 407, a Selective Inhibitor of the N-Domain of Angiotensin I-Converting Enzyme, Blocks in Vivo the Degradation of Hemoregulatory Peptide Acetyl-Ser-Asp-Lys-Pro with No Effect on Angiotensin I Hydrolysis

Christophe Junot, Marie-Françoise Gonzales, Éric Ezan et al. · Journal of Pharmacology and Experimental Therapeutics · 2001 · 88 citations

Medicine, Cardiology, Pharmacology +7

Protection of the Hydroxyphosphinyl Function of Phosphinic Dipeptides by Adamantyl. Application to the Solid-Phase Synthesis of Phosphinic Peptides

Athanasios Yiotakis, Stamatia Vassiliou, Vincent Dive · The Journal of Organic Chemistry · 1996 · 82 citations

Natural Sciences, Biochemistry, Chemistry +12